Rchr
J-GLOBAL ID：201801015816250361
Update date: Nov. 14, 2024
Kato Ken
カトウ ケン | Kato Ken
Affiliation and department：
Job title：
Chief of Department of Head and Neck, Esophageal Medical Oncology/Gastrointestinal Medical Oncology
Research field (1)：
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (1)：
- 2011 - 2014 Mechanistic analysis and prediction of infusion reactions
Papers (283)：
-
Motoo Nomura, Toshifumi Yamaguchi, Keisho Chin, Shinji Hato, Ken Kato, Eishi Baba, Hisahiro Matsubara, Hidenori Mukaida, Takako Yoshii, Masahiro Tsuda, et al. Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial. Annals of surgical oncology. 2024
-
Satoru Matsuda, Hiroya Takeuchi, Ken Kato, Ryunosuke Machida, Yoshinori Ito, Yasuhiro Tsubosa, Hiroyuki Daiko, Kazuo Koyanagi, Takashi Ogata, Takashi Fukuda, et al. Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109. Annals of Surgical Oncology. 2024
-
Shun Yamamoto, Ken Kato, Hiroyuki Daiko, Yoshinori Ito, Takeshi Kajiwara, Takashi Kojima, Hiroshi Miyata, Satoru Nakagawa, Masaki Ueno, Masaya Watanabe, et al. Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502. Future oncology (London, England). 2024. 1-6
-
Kenro Hirata, Kayo Yoshida, Chikatoshi Katada, Akinori Watanabe, Takahiro Tsushima, Toshifumi Yamaguchi, Sachiko Yamamoto, Hideki Ishikawa, Yasunori Sato, Chiyo K Imamura, et al. Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial. BMC cancer. 2024. 24. 1. 873-873
-
野崎 良子, 小熊 潤也, 石山 廣志朗, 栗田 大資, 久保 賢太郎, 久保 祐人, 宇都宮 大地, 伊賀上 翔太, 加藤 健, 大幸 宏幸. 上部消化管 術前治療+食道切除後の免疫チェックポイント阻害剤による補助療法の現状 食道扁平上皮癌に対する,術前化学療法後の術後nivolumab療法の安全性と有効性. 日本消化器外科学会総会. 2024. 79回. 488-488
ｍore...
MISC (114)：
-
Motoo Nomura, Katsuyuki Sakanaka, Ken Kato, Tomohiro Kadota, Yoshinori Ito, Ryunosuke Machida, Keita Sasaki, Tomoko Kataoka, Yasumasa Nishimura, Yuko Kitagawa. A randomized controlled phase III trial of comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer:JCOG1904/ARMADILLO study. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
-
Seiichiro Mitani, Ken Kato, Hiroyuki Daiko, Isao Nozaki, Takashi Kojima, Masahiko Yano, Satoru Nakagawa, Masaki Ueno, Masaya Watanabe, Shigeru Tsunoda, et al. Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: Supplementary analysis of the JCOG trial, JCOG0502. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
-
Tomoya Yokota, Ken Kato, Yasuo Hamamoto, Yasuhiro Tsubosa, Hirofumi Ogawa, Yoshinori Ito, Hiroki Hara, Takashi Ura, Takashi Kojima, Keisho Chin, et al. A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer. Annals of surgical oncology. 2020. 27. 2. 460-467
-
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. The Lancet. Oncology. 2019. 20. 11. 1506-1517
-
野村 基雄, 清水 充子, 大橋 真也, 三梨 桂子, 加藤 健, 小島 隆嗣, 坂中 克行, 武藤 学. 食道癌に対する根治的CRTとNivolumab併用による医師主導治験 Trial in progress. 日本癌治療学会学術集会抄録集. 2019. 57回. P9-5
ｍore...
Books (1)：
-
術前化学療法と術前化学放射線療法は,効果・安全性の面からどちらが良いか?
医事新報社 2017
Lectures and oral presentations (1)：
-
A randomized controlled phase III comparing CF (5-FU, CDDP) versus DCF (5-FU, CDDP, docetaxel) versus CF-RT as neoadjuvant treatment for locally advanced esophageal cancer
(International Symposium of Disease of Esophagus 2018)
Return to Previous Page
